Literature DB >> 28465653

Predictors of Hospitalization among Children on ART in Ethiopia: a Cohort study.

Abraham Haileamlak1, Tesfalem Hagos2, Workeabeba Abebe2, Loko Abraham3, Henok Asefa4, Alula M Teklu5.   

Abstract

BACKGROUND: Substantial progress has been made in the management of pediatric HIV infection in Ethiopia with the implementation of mother-to-child-prevention programs. Since the introduction of HAART in 2005, mortality among HIV-infected children has reduced while the rate of hospitalization was expected to rise. The purpose of this study, therefore, was to assess predictors of hospitalization in children on ART in seven university referral hospitals in Ethiopia.
METHODS: A prospective cohort study design was employed on children age 0-18 years as part of a multisite observational study. ART-experienced eligible and ART-naïve children with HIV/AIDS were enrolled into the Advanced Clinical Monitoring (ACM) till December 31, 2012 were included. From the database, information on hospitalization and other independent variables were extracted. Analysis was done using both SPSS for Windows version 16.0 and STATA. Descriptive analyses and modeling was done using logistic regression.
RESULTS: Of the 405 children on ART (174 experienced, 231 naive), 86 (20.7%) were hospitalized for various reasons; two children were excluded since they were hospitalized for unrelated conditions (appendicitis and burn). Fifty one (60.7%) of the eighty four admitted children were hospitalized in the first six months of ART initiation. Of the independent variables, only the presence of opportunistic infections and duration on ART were significantly associated with hospitalization both on bi-variable and multivariable analyses (P-value <0.05). As the duration on ART increased by one month, the risk of hospitalization decreased by 5.4%, which is statistically significant (P < 0.001). Whereas the incidence (number) of OI's increased by one, the risk of being hospitalized increased by 35.2% (P = 0.002). Of the individual opportunistic infections, pneumonia was found to be the only predictor of hospitalization (P-value = 0.002).
CONCLUSION: This study showed that nearly two-third of the hospitalization was within 6 months of initiation of ART; and presence of OI and duration on ART were the only predictors of hospitalization.

Entities:  

Keywords:  Children; HAART; HIV/AIDS; Hospitalization

Mesh:

Year:  2017        PMID: 28465653      PMCID: PMC5402799          DOI: 10.4314/ejhs.v27i1.6s

Source DB:  PubMed          Journal:  Ethiop J Health Sci        ISSN: 1029-1857


Introduction

The emergence of the HIV epidemic is one of the biggest public health challenges the world has ever seen in recent history. Since the confirmation of its existence HIV has affected all continents wildly spreading to children, adolescents and adults. Sub-Saharan Africa (SSA) is the epicenter of the epidemic and continues to carry the full brunt of its health and socioeconomic impact. Ethiopia is among the countries most affected by the HIV epidemic. With an estimated adult prevalence of 1.5%, Ethiopia has a large number of people living with HIV; and about 1 million AIDS orphans (1). Substantial progress has been made in the management of pediatric HIV infection worldwide, in SSA and Ethiopia with the implementation of mother-to-child-prevention programs. Early Infant diagnosis using DBS and subsequently the introduction of Highly Active Antiretroviral therapy (ART), however is lagging behind where an estimated 3.3 million children are still living with HIV, of whom 3.1 million live in sub-Saharan Africa. Although the exact prevalence of HIV in the children of Ethiopia is not known there are currently 134,586 children under 14 years living with HIV/AIDS (2). Mortality was high and premature before the introduction of HAART, reaching 35% in the first 12 months of life and 52% within 2 years of life of HIV-infected infant (3). Since 2004, however, following the introduction of ART, reductions in mortality and morbidity among HIV-infected children have been reported (4– 8). Hospitalization represents an important outcome measure and a reliable indicator for morbidity and mortality, as well as health service utilization. The four leading causes of admission to Tikur Anbessa hospital pediatric emergency department were severe pneumonia (38.6%), meningitis (7.2%), sepsis (5.6%) and heart diseases (4.6%) (3,9). In an earlier study done in the same facility, malnutrition (18.5%), neonatal disorders (16.8%), diseases of the respiratory system including pneumonia (10.6%) and infective and parasitic diseases (9.8%) were the four major causes of admission to all the wards (4, 10). Research elsewhere has shown that the rate of hospitalization is very high in children who are on HAART, particularly in the first 6 months of enrollment. For instance, in Thailand, Collins et al (2012) found hospitalization rates of 63 per 100 person years in the first 6 months on ART, declining to 10 per 100 person years after two years on HAART. In another Thai study, (5,11) the incidence of hospitalization was found to be 30.7% in the first six months of life, declining to 2.0% by the third year of life. A Brazilian study (6,12) found that 43.3% of children were hospitalized in the first three years of therapy. Although investigators have looked into the patterns and causes of hospitalization in children, there are little or no published studies investigating predictors of hospitalization in children on HAART. The purpose of this study, therefore, was to assess predictors of hospitalized children on ART in seven university referral hospitals in Ethiopia.

Patients and Methods

Background of Advanced Clinical Monitoring (ACM) of ART in Ethiopia: Seven public medical schools in Ethiopia; Addis Ababa, Defense, Gondar, Haromaya, Hawassa, Jimma, Makelle, Gondar and their affiliated hospitals agreed to establish an observational cohort study of HIV infected children and adults. The study was named the Advanced Clinical Monitoring (ACM) of ART in Ethiopia. The stakeholders were; The Federal Ministry of Health- represented by the Federal HIV/AIDS Prevention and Control Office (FHAPCO), the Ethiopian Health and Nutrition Research Institute (EHNRI) now renamed as Ethiopian Public Health Institute (EPHI) which hosted the central data and specimen repository, the Federal Science and Technology Commission (STC) the now renamed as Ministry of Science and Technology (FMoST), CDC-Ethiopia-the sponsors, and The Johns Hopkins University-Technical Support for Ethiopia on HIV/AIDS Initiative (JHU-TSEHAI) who provided technical assistance. The participating institutions signed a collaboration agreement in January 2006, and the project was formally launched in September 2006. However, enrolment of cases started in September 2009. An ART Register Database of all children initiated on ART since January 2005 was developed and maintained at each site. Each participating center contributed 20 randomly selected children from the ART Register database; the repository cohort consisted of 20 children per site who were ART naïve on entry to the cohort. Similar database was set for adult cases which is inclusive of children age 15–18 years. Eligibility for ART was according to Federal Ministry of Health Ethiopia ART guideline. Children were enrolled to the cohort after written informed consent (age 14–18 years) and through their guardians (below ten years). Children from ten to thirteen years old were also verbally assented. Baseline socio demographic, clinical and laboratory data was recorded on medical forms that were standardized at all seven ACM participating sites. During the screening visit, participants had baseline medical and laboratory evaluation; while eligibility assessment for ART was made by site level physicians. Consenting patients were enrolled to the study and followed up at two and four weeks, at three months after starting of ART, and every three months thereafter. Data on adherence, ongoing clinical care, hospitalizations were recorded. Data was entered in to software called ART Information System for Ethiopia, ARTISE, at site level and then transported to the central database electronically. All identifying information was removed before transferring data. A participant was recorded as lost to follow up after she/he had missed two scheduled visits and couldn't be contacted by telephone or through her/his emergency contact. Participants could withdraw from the database at any time by informing site staff. The national ethical clearance committee and IRBs of JHU and CDC gave approval to the study. Study design and Population: A longitudinal study design was a part of the multisite observational study. All children enrolled in the ACM pediatric database cohort and adolescents age 14–18 enrolled in the ACM adult and adolescent database cohort were included. Sample size calculations: All the 174 ART-experienced eligible participants and 231 ART-naïve participants who had been enrolled into the ACM till December 31, 2012 were considered (fig. 1). Missed values were excluded from the analysis list wise.
Figure 1

Flow chart showing distribution among different ACM cohort groups.

Flow chart showing distribution among different ACM cohort groups. From the database, data on hospitalization, background information at enrollment (Age, Sex, with whom the child is living), nutritional status at enrollment (Stunting, underweight, Wasting), laboratory monitoring (CD4 immune status) and clinical findings (WHO stage at enrollment) and treatment from enrollment to end of data collection (co-trimoxazole preventive therapy, Isoniazid Preventive Therapy, Duration of ART, Duration of ART before hospitalization, Regimen at enrollment) were extracted. In addition, data on reasons for hospitalization were extracted from the hospitalization abstraction sheet, Data Analysis: Descriptive analysis was done to explain each variable selected. Modeling was done using logistic regression. As an initial step, each factor's association with hospitalization was analyzed in uni-variable logistic regression. All factors significant at P-value< 0.05 level was considered for the multi-variable analysis. Backward stepwise selection was used to identify independent factors associated with hospitalization in the multi-variable analysis. The data flow is shown in figure 1. The frequency and distribution of the hospitalized cases was tabulated by principal diagnostic category as listed on the discharge report, including opportunistic infections, non-AIDS related conditions, immune reconstitution inflammatory syndrome (IRIS) and medication toxicities. The following operational definitions were used Hospitalization: any child or adolescent admitted to the health facility during the course of ART due to opportunistic infections, IRIS, drug related events, other infections and non-infectious illnesses with the exception of admission for procedures or accidents irrespective of duration of hospital stay. Child and/or adolescent: an individual below the age of 18 years. Opportunistic Infection (OI): any single or multiple disease(s) that occur(s) because of weakened immune system due to HIV infection [extensive molluscum contagiosum (5% body surface area), herpes zoster, recurrent or chronic upper respiratory tract infection (URTI), fungal nail infections, moderate or severe malnutrition, unexplained persistent diarrhea, unexplained persistent fever, oroesophageal candidiasis, oral hairy leukoplakia, acute necrotizing ulcerative gingivitis/ periodontitis, tuberculosis, severe pneumonia, lymphoid interstitial pneumonitis, unexplained anemia, thrombocytopenia and neutropenia, Pneumocystis carinii Pneumonitis (PCP), recurrent sever presumed bacterial infections, chronic herpes simples infection, Kaposi sarcoma, toxoplasmosis, HIV encephalopathy, CMV infection, cryptococcal meningitis, cerebral or B cell non-Hodgkin's lymphoma]. Immune Reconstitution Inflammatory Syndrome (IRIS): is defined as evidence of favorable response to HAART with a temporal association between the initiation of HAART and onset of disease. Drug related events: any unfavorable/ undesirable condition with possible relationship to ARVs. Other infections: infections other than those listed under OI above. Duration of ART: the duration of treatment from initiation of ART up to end of enrolment, December 31/2012. Duration of ART before hospitalization- the duration of ART treatment up to hospitalization CD4 is classified as normal, moderate, and severe immune deficiency as per the 2009 report of the committee of infectious disease, American Academy of Pediatrics (13). Malnutrition: is the presence of underweight, stunting and/or wasting as defined by WHO Z score (14).

Results

During the cohort period, 405 children on ART, 174 from experienced and 231 from naive were enrolled. Eighty six children (20.7%) were hospitalized for various reasons; two of them were not considered as hospitalized during our analysis since they were admitted for appendicitis and burn. Fifty one out of 84 (60.7%) children hospitalized for HIV/AIDS related causes were admitted in the first six months of ART initiation (fig. 1, table 1). The 405 children were from the seven participating university hospitals. The distribution of cases among participating facilities was homogenous as shown in table 1.
Table 1

Frequency of cases by facility and intra-cluster homogeneity analyses among the seven facilities.

FacilityHospitalizedNon-HospitalizedOdds95% Conf. Interval
Tikur Anbesa12570.2110.113–0.392
Army10320.3130.154–0.636
Gondar18520.3460.203–0.592
Jimma11420.2620.135–0.509
Mekelle13470.2770.150–0.511
Haramaya7440.1590.072–0.353
Hawassa13470.2770.150–0.511

Test of homogeneity (equal odds): chi2(6) = 3.35, Pr>chi2 = 0.7643, Score test for trend of odds: chi2(1) = 0.06, Pr>chi2 = 0.8062

Frequency of cases by facility and intra-cluster homogeneity analyses among the seven facilities. Test of homogeneity (equal odds): chi2(6) = 3.35, Pr>chi2 = 0.7643, Score test for trend of odds: chi2(1) = 0.06, Pr>chi2 = 0.8062 Participants age was categorized based the national ART guideline age category. Accordingly, 260 (64.2) of the children were in the age group of 5–14 years with median age of 7 years. Two hundred seventy three (84.5%) of the children were living with their parents and most of them 255(64.6%) were WHO stage III and IV at initiation of ART. Almost all were kept on first line ART regimen; nearly 80% of them on AZT based regimen. When we see the nutritional status of these children, 86 (21.2%) were underweight, 74 (18.3%) were stunted while 65 (17.8%) were wasted. Three hundred eighty (93.8%) of the children were on Cotrimoxazole and only 2% on isoniazid preventive therapy. One hundred forty five (45.2%) and 143 (44.5%) of the children had severe and moderate immune deficiency, respectively while only 10% had normal CD4 count. One hundred seventy two (42.5%) of the children had at least one episode of opportunistic infections. For two variables (ART Regimen type at initiation and Wasting) values were missing since height for 36 and weight for 4 children were not recorded. For one child there was no record for the ART regimen type she was on at treatment initiation (table 2).
Table 2

Background characteristics of children on ART in seven Ethiopian Referral Hospitals.

VariablesCategoriesFrequencyPercentage
HospitalizationYes8420.7
No32179.3
SexMale20751.1
Female19848.9
Age Category in year0–411728.9
5–919648.4
10-189222.7
Child live withParents27384.5
Others5015.5
Baseline WHO StageStage I & II14035.4
Stage III & IV25564.6
ART Regimen at initiation¥AZT or D4T+3TC+NVP31878.7
AZT or D4T+3TC+EFV7017.3
Other 1st line regimens153.7
Second line10.3
Under WeightYes8621.2
No31978.8
StuntedYes7418.3
No33181.7
Wasted¥Yes6517.8
No30082.2
CPTYes38093.8
No256.2
IPTYes82.0
No39798.0
CD4 count at ART startNormal3310.3
Moderate14344.5
Severe14545.2
OIsYes17242.5
No23357.5

Values do not add up 405 as some information was not captured.

Background characteristics of children on ART in seven Ethiopian Referral Hospitals. Values do not add up 405 as some information was not captured. In identifying the possible predictors of hospitalization from dependent variables, logistic regression was done. Accordingly, of the exploratory variables, using bi-variable analyses only showed the presence of opportunistic infections and duration on ART associated with hospitalization (table 3).
Table 3

Association of background characteristics with hospitalization using bi-variable logistic regression

Hospitalization

YesNo
VariablesCategoriesN (%)N (%)COR95% CIP-value
SexFemale36(18.2)162(81.8)1
Male48(23.2)159(76.8)1.360.842.210.215
Age Category< 5 years28(23.9)89(76.1)1
5 – 9 years40(20.4)156(79.6)0.820.471.410.465
10 – 18 years16(17.4)76(82.6)0.670.341.330.251
Child live withParents60(22)213(78)1.280.592.790.529
Others9(18)41(82)1
Baseline WHO StageStage I &II23(16.4)117(83.6)0.650.381.110.117
Stage III &IV59(23.1)196(76.9)1
ART Regimen at initiationAZT or D4T+3TC+NVP66(20.8)252(79.2)1
AZT or D4T+3TC+EFV14(20)56(80)0.960.51.820.888
Other 1st line regimens4(26.7)11(73.3)1.390.434.50.584
Under WeightYes19(22.1)67(77.9)1.110.621.980.728
No65(20.4)254(79.6)1
StuntedYes18(24.3)56(75.7)1.290.712.340.401
No66(19.9)265(80.1)1
WastedYes18(27.7)47(72.3)1.710.923.160.09
No55(18.3)245(81.7)1
CPTYes81(21.3)299(78.7)1
No3(12)22(88)0.50.151.720.274
INHYes1(12.5)7(87.5)1
No83(20.9)314(79.1)1.850.2315.250.567
CD4 CategorySevere25(17.2)120(82.8)1
Moderate27(18.9)116(81.1)1.120.612.040.718
Normal8(24.2)25(75.8)1.540.623.790.353
OIYes44(25.6)128(74.4)1.661.022.670.04
No40(17.2)193(82.8)1
Number of OI's1.231.061.40.006
Duration on ART0.930.910.95<0.001
Association of background characteristics with hospitalization using bi-variable logistic regression The two variables- OIs and duration on ART remained to be strong predictors of hospitalization on multivariable analyses. As the duration on ART increased by one month, the risk of hospitalization decreased by 5.4% which is statistically significant (P < 0.001). However, when the incidence (number) of OI's increased by one, the risk of being hospitalized increased by 35.2%, P = 0.002 (table 4).
Table 4

Predictors of hospitalization among children on ART in Ethiopia

VariablesAOR95% CI for AORP-Value
Duration on ART in months0.9260.9060.946< 0.001
OI_Count1.3521.1221.6310.002
Predictors of hospitalization among children on ART in Ethiopia The study tried to identify which opportunistic infections could predict hospitalization. In doing so the commonly seen opportunistic infections were tallied and bi-variable regression done for hospitalization against the presence or presence of individual opportunistic infection and pneumonia was found to be the only predictor of hospitalization (P-value = 0.002) (table 5).
Table 5

Opportunistic infections versus hospitalization among children on ART in Ethiopia

Hospitalization

YesNo
OI TypeN (%)N (%)P-Value
PneumoniaNo52(17.2)251(82.8)0.002
Yes32(31.4)70(68.6)
Oral CandidiasisNo78(20.6)301(79.4)0.761
Yes6(23.1)20(76.9)
MalnutritionNo71(20.1)283(79.9)0.371
Yes13(25.5)38(74.5)
Other OINo72(20.9)272(79.1)0.823
Yes12(19.7)49(80.3)
Opportunistic infections versus hospitalization among children on ART in Ethiopia Although there were over eleven disease categories as reasons for hospitalization, only three - acute respiratory infections, malnutrition and neurological problems accounted for 33 (38.4%), 9 (10.5%) and 7 (8.2%), respectively (Fig 2).
Figure 2

Frequency distribution of causes of hospitalization

Frequency distribution of causes of hospitalization

Discussion

This Prospective Cohort study aimed to identify the predictors of hospitalization among children in Ethiopia. Eighty four children (20.7%) out of the total 405 in the study were hospitalized at least once for various reasons. The result is similar to a study done in Thailand where 35% children were hospitalized (5). However, this study may not be representative to all children with HIV in Ethiopia as many others may be hospitalized in district or regional hospitals. The majority of the children (60.7%) were admitted within the first 24 weeks of HAART initiation, which is not different from other similar studies. The median time of ART among those hospitalized in West Africa was 9.8 months (15). The first 6 months of treatment is characterized by high mortality of hospitalization until the patient gets stabilized (5). The mean age at HAART initiation in our study population was 7 years which is similar to the study done in Thailand where it was 7.6 years (5). This finding is a bit late than the one reported in West Africa where the HAART initiation age was 3 years (15). While HIV in children is known for its fast progression, the mortality is quiet high and if not treated timely.This study finding indicates that there has been delay in diagnosing and initiating HAART. The WHO reports that without treatment, 50% of children would die before their 2nd birth day and if delayed until 5 years, 75% of them would die (16); emphasizing the need for early infant diagnosis and treatment. Malnutrition in the form of underweight, stunting or wasting based on the WHO Z-score was common among those children. Eighty six children (21.2%) were underweight, 18.3% stunted and 17.8% wasted. Malnutrition is considered to be the most common manifestation of HIV infected children in developing countries (17, 18). A study that dealt with clinical profile of hospitalized HIV -infected children in Bangladesh found that for children below 5 years of age, the mean Weight for Age Z-score (WAZ) was −2.1 and Height for Age Z-score (HAZ) HAZ was −2.9 while for older than 5 years of age the mean BMI was 12.6 (19). More than half 44(52.4%) of those hospitalized had at least one episode of opportunistic infection (OI), while only 128(39.9%) of those non-hospitalized had OI. Presence of OI was found to be associated with hospitalization with P-value of <0.05 using both bi-variable and multi-variable analysis. A study done among children and young adults in United States of America HIV clinics revealed that CD4 count and HIV-1RNA were strongly associated with hospitalization (20). We don't have data on viral load in most of our cases and the CD4 count (though few missing) was not found to be significantly associated with hospitalization. Presence of OI could be a proxy indicator of low CD4. The other variable which was associated with hospitalization was duration on ART-the lesser the duration the higher the chance of getting hospitalized. This indicated that children were initiated late after they developed OIs and soon after treatment initiation got hospitalized either due to the OIs or IRIS. Care interventions aiming at identifying the earliest possible HIV-infected infants and treating them according to current guidelines would drastically reduce cost of HIV care including costs related to hospitalization (15). Studies in Thailand and South Africa have shown that early ART initiation incur lower in patient care costs (21, 22). The major causes of hospitalization were pneumonia 33(38.1), malnutrition 9(10.5%) and neurological conditions like seizure and focal neurological deficits. Furthermore, this study also revealed pneumonia to be the single predicator of hospitalizations among OIs. Other studies also showed that pneumonia to be the leading cause of hospitalizations (5, 15). In conclusion, this cohort study showed that HAART initiation age was late, presence of OI and duration on ART were the only predictors of hospitalization and pneumonia was the leading cause of hospitalization. This study might not be generalized to all children enrolled in ART in Ethiopia such as those following at primary level health care as it is done in Tertiary teaching hospitals.
  15 in total

1.  Hospitalization and mortality among HIV-infected children after receiving highly active antiretroviral therapy.

Authors:  Thanyawee Puthanakit; Linda Aurpibul; Peninnah Oberdorfer; Noppadon Akarathum; Suparat Kanjananit; Pornphun Wannarit; Thira Sirisanthana; Virat Sirisanthana
Journal:  Clin Infect Dis       Date:  2007-01-09       Impact factor: 9.079

2.  Impact of HAART on growth and hospitalization rates among HIV-infected children.

Authors:  Lilian Martins Oliveira Diniz; Marcelle Marie Martins Maia; Letícia Silveira Camargos; Leandro Custódio Amaral; Eugênio Marcos Andrade Goulart; Jorge Andrade Pinto
Journal:  J Pediatr (Rio J)       Date:  2011-03-16       Impact factor: 2.197

3.  Demographic & clinical profile of HIV infected children accessing care at Tambaram, Chennai, India.

Authors:  S Rajasekaran; L Jeyaseelan; K Raja; N Ravichandran
Journal:  Indian J Med Res       Date:  2009-01       Impact factor: 2.375

4.  Mortality of infected and uninfected infants born to HIV-infected mothers in Africa: a pooled analysis.

Authors:  Marie-Louise Newell; Hoosen Coovadia; Marjo Cortina-Borja; Nigel Rollins; Philippe Gaillard; Francois Dabis
Journal:  Lancet       Date:  2004 Oct 2-8       Impact factor: 79.321

Review 5.  Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa.

Authors:  Catherine G Sutcliffe; Janneke H van Dijk; Carolyn Bolton; Deborah Persaud; William J Moss
Journal:  Lancet Infect Dis       Date:  2008-08       Impact factor: 25.071

6.  Clinical profile of hospitalized HIV-infected children in Bangladesh, a low-HIV-prevalence country.

Authors:  Lubaba Shahrin; Daniel T Leung; Nashaba Matin; Chowdhury Ali Kawser; Mohammed Moshtaq Pervez; Mohammod Jobayer Chisti
Journal:  Paediatr Int Child Health       Date:  2013-12-06       Impact factor: 1.990

Review 7.  Effectiveness of pediatric antiretroviral therapy in resource-limited settings: a systematic review and meta-analysis.

Authors:  Andrea L Ciaranello; Yuchiao Chang; Andrea V Margulis; Adam Bernstein; Ingrid V Bassett; Elena Losina; Rochelle P Walensky
Journal:  Clin Infect Dis       Date:  2009-12-15       Impact factor: 9.079

8.  Early antiretroviral therapy and mortality among HIV-infected infants.

Authors:  Avy Violari; Mark F Cotton; Diana M Gibb; Abdel G Babiker; Jan Steyn; Shabir A Madhi; Patrick Jean-Philippe; James A McIntyre
Journal:  N Engl J Med       Date:  2008-11-20       Impact factor: 91.245

9.  Trends in hospitalizations among children and young adults with perinatally acquired HIV.

Authors:  Stephen A Berry; Kelly A Gebo; Richard M Rutstein; Keri N Althoff; P Todd Korthuis; Aditya H Gaur; Stephen A Spector; Robert Warford; Baligh R Yehia; Allison L Agwu
Journal:  Pediatr Infect Dis J       Date:  2014-05       Impact factor: 2.129

10.  Early and late direct costs in a Southern African antiretroviral treatment programme: a retrospective cohort analysis.

Authors:  Rory Leisegang; Susan Cleary; Michael Hislop; Alistair Davidse; Leon Regensberg; Francesca Little; Gary Maartens
Journal:  PLoS Med       Date:  2009-12-01       Impact factor: 11.069

View more
  3 in total

1.  Incidence of Pneumonia and Predictors Among Human Immunodeficiency Virus Infected Children at Public Health Institutions in the Northwest Part of Ethiopia: Multicenter Retrospective Follow-Up Study.

Authors:  Teshale Mengesha; Tsegasew Embiale; Molla Azmeraw; Gashaw Kerebeh; Sileshi Mulatu; Fentahun Meseret; Minyichil Birhanu
Journal:  Pediatric Health Med Ther       Date:  2022-02-11

2.  Incidence of common opportunistic infections among HIV-infected children on ART at Debre Markos referral hospital, Northwest Ethiopia: a retrospective cohort study.

Authors:  Mamaru Wubale Melkamu; Mulugeta Tesfa Gebeyehu; Abebe Dilie Afenigus; Yitbarek Tenaw Hibstie; Belisty Temesgen; Pammla Petrucka; Animut Alebel
Journal:  BMC Infect Dis       Date:  2020-01-16       Impact factor: 3.090

3.  HIV/AIDS treatment failure and associated factors in Ethiopia: meta-analysis.

Authors:  Aklilu Endalamaw; Mengistu Mekonnen; Demeke Geremew; Fikadu Ambaw Yehualashet; Hiwot Tesera; Tesfa Dejenie Habtewold
Journal:  BMC Public Health       Date:  2020-01-20       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.